BioNano Genomics Announces $3M Direct Offering Initiative
Company Announcements

BioNano Genomics Announces $3M Direct Offering Initiative

BioNano Genomics ( (BNGO) ) has shared an update.

Bionano Genomics announced a $3 million registered direct offering involving the sale of nearly 9.9 million shares and accompanying warrants, priced at $0.3039 per share. The Series C and D Warrants, which allow further stock purchases at the same price, are set to expire five years and 18 months post-approval, respectively. The proceeds are intended for general corporate purposes, with H.C. Wainwright & Co. acting as the exclusive placement agent. The offering highlights Bionano’s strategic financial maneuvers to bolster its genomic solutions business.

See more insights into BNGO stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBionano Genomics to sell 9.88M shares at 30.39c in registered direct offering
TheFlyBionano Genomics adjourns Special Meeting of Stockholders
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App